Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€5.10
19.04.21
-
19.04.22
-76.52%
20.04.22

Could be very worthwhile Investment >20% year
Simone123 
19.04.21 0%
sell
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.76
04.04.22
€0.000
04.04.23
-33.28%
18.04.22

EBIT decline > 20% expected
Revenue decline > 20% expected
Very low/no dividend yield expected
Sustainability is not important
Marianka 
04.04.22 50%
sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€1.00
06.04.23
-22.00%
18.04.22

Probably not worthwhile Investment
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
Marianka 
06.04.22 70%
sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€0.000
06.04.23
-22.00%
18.04.22

Could be worthwhile Investment >10% per year
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
dimontalban 
06.04.22 50%
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€9.86
12.04.22
-
12.04.23
-0.02%
16.04.22

Could be worthwhile Investment >10% per year
Vassago1 
12.04.22 50%
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€184.00
02.04.22
€200.00
02.04.23
-15.22%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
skatcup 
02.04.22 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€6.45
27.11.21
€3.30
27.11.22
-52.69%
12.04.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
27.11.21 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€145.98
11.11.21
€75.00
11.11.22
-63.74%
11.04.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
11.11.21 60%
buy
Stratec SE

Start price
Target price
Perf. (%)
€116.60
03.03.21
€165.00
03.10.22
3.43%
06.04.22

Could be worthwhile Investment >10% per year
Covacoro 
03.03.21 70%
buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€25.40
28.03.22
-
28.03.23
25.20%
02.04.22

Risky Investment
Global_Player 
28.03.22 50%
sell
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€59.50
22.03.22
-
22.03.23
-20.59%
31.03.22

Risky Investment
Global_Player 
22.03.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.30
27.11.21
€28.00
27.11.22
-44.88%
30.03.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
27.11.21 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.96
07.03.22
-
07.03.23
27.52%
28.03.22

Could be worthwhile Investment >10% per year
robertinio 
07.03.22 100%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€11.50
21.03.21
-
21.03.22
-64.30%
22.03.22

Could be very worthwhile Investment >20% year
Innovative
Maxfloh 
21.03.21 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
melinda 
20.02.22 50%
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€3.04
20.02.22
€4.00
20.03.22
-11.39%
21.03.22

Could be worthwhile Investment >10% per year
melinda 
20.02.22 50%
sell
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€81.03
15.03.22
-
15.03.23
-14.84%
20.03.22

Could be worthwhile Investment >10% per year
Vassago1 
15.03.22 50%
buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
07.03.22
-
07.03.23
0.60%
19.03.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
kostojunior 
07.03.22 60%
sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€20.53
14.03.22
€14.00
14.03.23
3.70%
16.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
14.03.22 60%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€30.25
13.10.21
€34.00
30.07.22
-32.13%
14.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
13.10.21 60%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.39
30.01.22
€4.00
30.01.23
-10.83%
14.03.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
30.01.22 50%
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€9.50
01.10.21
-
01.10.22
-58.63%
13.03.22

Kilianhammernick 
01.10.21 50%
buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€4.66
12.07.21
-
12.07.22
48.95%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€13.28
12.03.21
€24.00
12.03.22
-62.26%
12.03.22

Could be very worthwhile Investment >20% year
woelli 
12.03.21 60%
sell
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€26.55
10.03.21
-
10.03.22
-86.89%
11.03.22

Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
shadow 
10.03.21 0%